FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 1 filers reported holding FLEXION THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | +50.0% | 1,963 | +103.8% | 0.00% | – |
| Q2 2021 | $8,000 | -100.0% | 963 | -77.6% | 0.00% | – |
| Q1 2021 | $38,486,000 | +427522.2% | 4,300 | +469.5% | 0.00% | – |
| Q4 2020 | $9,000 | -18.2% | 755 | -28.4% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 1,055 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +75.0% | 1,055 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -61.9% | 1,055 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +50.0% | 1,055 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | +16.7% | 1,055 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -42.9% | 1,055 | -5.1% | 0.00% | -100.0% |
| Q3 2018 | $21,000 | -72.4% | 1,112 | -62.2% | 0.00% | -80.0% |
| Q2 2018 | $76,000 | +38.2% | 2,942 | +19.3% | 0.01% | +25.0% |
| Q1 2018 | $55,000 | -9.8% | 2,467 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $61,000 | +48.8% | 2,467 | +43.0% | 0.01% | +25.0% |
| Q3 2017 | $41,000 | +583.3% | 1,725 | +475.0% | 0.00% | +300.0% |
| Q2 2017 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $748,000 | 1.50% |
| Novo Holdings A/S | 950,161 | $14,224,000 | 1.49% |
| GILDER GAGNON HOWE & CO LLC | 4,307,870 | $64,467,000 | 1.28% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,097,463 | $16,424,000 | 0.90% |
| Monashee Investment Management LLC | 35,000 | $524,000 | 0.82% |
| WALL STREET ASSOCIATES | 113,400 | $1,697,000 | 0.68% |
| Convector Capital Management, LP | 24,000 | $359,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 891,274 | $13,338,000 | 0.48% |
| WASATCH ADVISORS LP | 835,781 | $12,507,000 | 0.19% |
| SHEPHERD KAPLAN KROCHUK, LLC | 41,755 | $625,000 | 0.16% |